학술논문
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study
Document Type
Article
Author
Source
In: Clinical Hematology International . (Clinical Hematology International, December 2022, 4(4):133-143)
Subject
Language
English
ISSN
25900048